Multiparametric MRI usage data for your Trust
I am writing to you under the Freedom of Information Act to request the following information from your Trust.
Within your Trust, we would be grateful for the following information at your earliest convenience:
1. Do you conduct multi-parametric MRI (mpMRI) scans (using T2-weighted, diffusion-weighted and dynamically enhanced sequences) before prostate biopsies?
If no, it would be helpful to know what the main reasons are:
If yes, it would be helpful if you can you provide an estimate of the percentage of men who receive an mpMRI scan before prostate biopsy:
2. How many scanners do you have available to use for mpMRI scans before prostate biopsy?
3. For each individual scanner used for mpMRI scans before prostate biopsy, please provide the following:
• Make
• Model
• Magnetic field strength
• Age
• When the scanner is due to be replaced
4. How many mpMRI scans before prostate biopsy do you estimate you carry out per year?
• 0
• Up to 50
• 50 -100
• 100 – 250
• 250 – 500
• 500 – 750
• 750 – 1000
• More than 1000
5.i. Do you intend to increase the number of mpMRI scans before prostate biopsy following the first results from the large clinical trial PROMIS?
The ASCO 2016 abstract has shown mpMRI as a triage test can identify one quarter of men (27%) who might safely avoid unnecessary biopsy, without impairing the detection of clinically significant cancer (http://abstract.asco.org/176/AbstView_17...).
5.ii If yes, do you currently have sufficient resources and capacity to cope with this increase?
The information you provide may be re-used publicly. We look forward to hearing from you soon.
Yours sincerely,
Dr Ali Cooper
Knowledge Manager
Prostate Cancer UK
4th Floor, Counting House
53 Tooley Street
London
SE1 2QN
0203 310 7000
Dear Oxford University Hospitals NHS Trust,
The response to this FOI request is now overdue. Please can you send a reply asap?
Many thanks,
Ali Cooper
Dear Oxford University Hospitals NHS Trust/Valerie Gray,
I am re-sending this request due to not receiving it the first time. I have also sent it directly to the team email address and to Valerie Gray's email address.
I am writing to you under the Freedom of Information Act to request the following information from your Trust.
Within your Trust, we would be grateful for the following information at your earliest convenience:
1. Do you conduct multi-parametric MRI (mpMRI) scans (using T2-weighted, diffusion-weighted and dynamically enhanced sequences) before prostate biopsies?
If no, it would be helpful to know what the main reasons are:
If yes, it would be helpful if you can you provide an estimate of the percentage of men who receive an mpMRI scan before prostate biopsy:
2. How many scanners do you have available to use for mpMRI scans before prostate biopsy?
3. For each individual scanner used for mpMRI scans before prostate biopsy, please provide the following:
• Make
• Model
• Magnetic field strength
• Age
• When the scanner is due to be replaced
4. How many mpMRI scans before prostate biopsy do you estimate you carry out per year?
• 0
• Up to 50
• 50 -100
• 100 – 250
• 250 – 500
• 500 – 750
• 750 – 1000
• More than 1000
5.i. Do you intend to increase the number of mpMRI scans before prostate biopsy following the first results from the large clinical trial PROMIS?
The ASCO 2016 abstract has shown mpMRI as a triage test can identify one quarter of men (27%) who might safely avoid unnecessary biopsy, without impairing the detection of clinically significant cancer (http://meetinglibrary.asco.org/content/1...).
5.ii If yes, do you currently have sufficient resources and capacity to cope with this increase?
The information you provide may be re-used publicly. We look forward to hearing from you soon.
Yours sincerely,
Dr Ali Cooper
Thank you.
Valerie Gray
Freedom of Information Officer
Planning & Information
Oxford University Hospitals NHS Foundation Trust
The John Radcliffe Hospital
Headley Way | Headington | Oxford | OX3 9DU
Tel: 01865 572470
Email: [email address]
Recipients should be aware that all emails received or sent by this Trust are subject to the Freedom of Information Act 2000 and therefore information within them may be disclosed to a third party. Please note that under our obligations to the Data Protection Act 1998, we will not disclose any personal information without your consent.
Martin Abrams (Prostate Cancer UK) left an annotation ()
Dear Ms. Cooper,
I am writing to respond to your request sent on the 4th August 2016. OUHFT can confirm that it holds the data that you requested.
1. Do you conduct multi-parametric MRI (mpMRI) scans (using T2-weighted, diffusion-weighted and dynamically enhanced sequences) before prostate biopsies? YES
If no, it would be helpful to know what the main reasons are:
If yes, it would be helpful if you can you provide an estimate of the percentage of men who receive an mpMRI scan before prostate biopsy: The Trust is unable to provide this information – data not readily available
2. How many scanners do you have available to use for mpMRI scans before prostate biopsy? 2 scanners
3. For each individual scanner used for mpMRI scans before prostate biopsy, please provide the following:
• Make: GE
• Model: HDX Twin Speed
• Magnetic field strength: 1.5T
• Age: 10yrs
• When the scanner is due to be replaced: Replacement is in line with RCR guidelines
4. How many mpMRI scans before prostate biopsy do you estimate you carry out per year? 1000 less or greater
5.i. Do you intend to increase the number of mpMRI scans before prostate biopsy following the first results from the large clinical trial PROMIS? YES
The ASCO 2016 abstract has shown mpMRI as a triage test can identify one quarter of men (27%) who might safely avoid unnecessary biopsy, without impairing the detection of clinically significant cancer (http://meetinglibrary.asco.org/content/1...).
5.ii If yes, do you currently have sufficient resources and capacity to cope with this increase? The Trust is unable to provide this information – data not readily available
NB: More work is required to pull data for Q1 and Q5 and this may exceed the cost limit of £450, s12 under FOIA.
Please note that on 1 November 2011 the Oxford Radcliffe Hospitals NHS Trust (ORH) merged with the Nuffield Orthopaedic Hospital NHS Trust (NOC) to form the Oxford University Hospitals NHS Trust (OUH). Our response reflects these changes. Therefore, we consider that Oxford University Hospitals Trust has released to you all of the information that it holds in relation to your request.
Internal review
If you are dissatisfied with the service or response to your request you can ask for an internal review by writing to:
Eileen Walsh, Director of Assurance, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU.
If you remain dissatisfied with the handling of your request or complaint, you have a right to appeal to the Information Commissioner at:
The Information Commissioner's Office,
Wycliffe House, Water Lane,
Wilmslow,
Cheshire,
SK9 5AF.
Telephone: 0303 123 1113 Website: www.ico.gov.uk
Provision of this information does not constitute permission for its commercial re-use in terms of the Re-Use of Public Sector Information Regulations 2005. You are free to use the information for your own use, including for non-commercial research purposes. The information may also be used for the purposes of news reporting. However, any other type of re-use will require permission from the Oxford University Hospitals NHS Trust.
Yours sincerely,
Valerie Gray
Freedom of Information Officer
Planning & Information
Oxford University Hospitals NHS Foundation Trust
The John Radcliffe Hospital
Headley Way | Headington | Oxford | OX3 9DU
Tel: 01865 272470
Email: valerie.gray@ouh.nhs.uk
Martin Abrams (Prostate Cancer UK) left an annotation ()
Dear Valerie
Thank you for the information.
You have only provided information on one scanner – please can you send details for the 2nd scanner?
Also, your answer to Q4 (“1000 less or greater”) does not make sense. Please select from:
• 0
• Up to 50
• 50 -100
• 100 – 250
• 250 – 500
• 500 – 750
• 750 – 1000
• More than 1000
Finally, I will await your responses to Q1 (the % part) and Q5b.
Thanks
Ali
Martin Abrams (Prostate Cancer UK) left an annotation ()
Dear Dr Ali,
Please find:
Information re the two scanners
• Make: GE
• Model: 750
• Magnetic field strength: 3T
• Age: 6yrs
• When the scanner is due to be replaced: We aim to replace in line with RCR guidelines
• Make: GE
• Model: HDX Twinspeed
• Magnetic field strength: 1.5T
• Age: 10 yrs
• When the scanner is due to be replaced: We aim to replace in line with RCR guidelines
Information on Q4
• 0
• Up to 50
• 50 -100
• 100 – 250
• 250 – 500
• 500 – 750
• 750 – 1000
• More than 1000
I have responded to Q1 and 5b.
Please do not hesitate to contact me if anything.
Regards,
Valerie Gray
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now
Martin Abrams (Prostate Cancer UK) left an annotation ()
Update email:
Dear Sir/Madam
Thank you for your request in which you asked for information the trust may hold.
Your request is being considered and Oxford University Hospitals NHS Foundation Trust will respond within 20 working days in compliance with the Freedom of Information Act 2000.
There may be a fee payable for this information. You will be informed if this is the case and you can decide if you wish to proceed with your request.
If appropriate, the information requested can be made available in alternative formats, including other languages, Braille, large print, and
CD’s. If you require any of these formats then please let me know.
Please contact me if you have any further enquiries about your request. I would be grateful if you could quote the reference number given at the top of this email.
Regards,
Valerie Gray
Freedom of Information Officer
Planning & Information
Oxford University Hospitals NHS Foundation Trust
The John Radcliffe Hospital
Headley Way | Headington | Oxford | OX3 9DU
Tel: 01865 572470
Email: valerie.gray@ouh.nhs.uk
Recipients should be aware that all emails received or sent by this Trust are subject to the Freedom of Information Act 2000 and therefore information within them may be disclosed to a third party. Please note that under our obligations to the Data Protection Act 1998, we will not disclose any personal information without your consent.